Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Post by deninsaskon Mar 16, 2007 1:23pm
397 Views
Post# 12432168

Woody for Transition Therapeutics? GPP is !!

Woody for Transition Therapeutics? GPP is !! "Just think.... One firm gets horny for this thing(just one), and we will see why the U.S is such a sought after market to trade on." Geez whocares, firm and horny in the same sentence......brave......LOL!! But I think you're right.........with only 500,000 shares being voted against the SC out of 185,000,000 the writing is on the wall. Everyone, but for a few non-savvy investors, wants their investment in Transition to be marginable including GPP ,FMR, Acuity. There are million upon millions of retail investors down there who will follow the deep pockets when they get feelin kinda Woody for Transition. Anyone that thinks GPP will sell into the TSX is wrong. GPP bought into Transition for AZD-103 plain and simple and have an agreement with them, as reported, for procedures to be followed post Nasdaq (GPP's written Words) Listing..........the only reporting firm to have such an agreement........Dr. Cruz just reiterated this publicly just recently. Just too much upside to Transition with AZD-103 having all the attributes of The Gold Standard AD Drug. $10-$15 BILLION market in the US alone is a huge opportunity for all involved. GPP is Woody for Transition Therapeutics!!.........
Bullboard Posts